TXMD Financial Statements

Balance sheet, income statement, cash flow, and dividends for Therapeuticsmd Inc (TXMD).


$9.92M Market Cap.

As of 03/27/2025 5:00 PM ET (MRY) • Disclaimer

TXMD Market Cap. (MRY)


TXMD Shares Outstanding (MRY)


TXMD Assets (MRY)


Total Assets

$38.82M

Total Liabilities

$11.45M

Total Investments

$0

TXMD Income (MRY)


Revenue

$1.76M

Net Income

-$2.18M

Operating Expense

$6.52M

TXMD Cash Flow (MRY)


CF Operations

$732.00K

CF Investing

$0

CF Financing

$0

TXMD Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

TXMD Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$38,822,000 (-10.36%)

$43,309,000 (-52.12%)

$90,458,000 (-46.62%)

$169,472,000 (-6.68%)

Assets Current

$12,259,000 (3.93%)

$11,796,000 (-78.69%)

$55,351,000 (-53.67%)

$119,468,000 (-6.96%)

Assets Non-Current

$26,563,000 (-15.71%)

$31,513,000 (-10.24%)

$35,107,000 (-29.79%)

$50,004,000 (-6.02%)

Goodwill & Intangible Assets

$4,321,000 (-29.14%)

$6,098,000 (-12.17%)

$6,943,000 (-2.81%)

$7,144,000 (-82.76%)

Shareholders Equity

$27,370,000 (-6.55%)

$29,287,000 (-16.66%)

$35,143,000 (137.54%)

-$93,621,000 (24.50%)

Property Plant & Equipment Net

$6,102,000 (-11.22%)

$6,873,000 (-10.25%)

$7,658,000 (-15.45%)

$9,057,000 (-21.30%)

Cash & Equivalents

$5,059,000 (16.92%)

$4,327,000 (-91.23%)

$49,317,000 (-24.02%)

$64,907,000 (-19.36%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$3,562,000 (15.28%)

$3,090,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$258,000 (855.56%)

$27,000 (-98.75%)

$2,162,000 (-35.90%)

$3,373,000 (-83.99%)

Accumulated Retained Earnings (Deficit)

-$951,822,000 (-0.23%)

-$949,641,000 (-1.09%)

-$939,363,000 (10.65%)

-$1,051,360,000 (-19.62%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$5,542,000 (-15.16%)

$6,532,000 (-11.36%)

$7,369,000 (-96.25%)

$196,332,000 (-20.31%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$188,269,000 (0%)

Debt Non-Current

$5,542,000 (-15.16%)

$6,532,000 (-11.36%)

$7,369,000 (-8.61%)

$8,063,000 (-96.73%)

Total Liabilities

$11,452,000 (-18.33%)

$14,022,000 (-74.65%)

$55,315,000 (-78.98%)

$263,093,000 (-13.91%)

Liabilities Current

$5,166,000 (-24.63%)

$6,854,000 (-85.37%)

$46,839,000 (-81.48%)

$252,891,000 (326.91%)

Liabilities Non-Current

$6,286,000 (-12.30%)

$7,168,000 (-15.43%)

$8,476,000 (-16.92%)

$10,202,000 (-95.86%)

TXMD Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$1,761,000 (35.25%)

$1,302,000 (-98.14%)

$69,963,000 (2619.12%)

$2,573,000 (-96.03%)

Cost of Revenue

$0 (0%)

$0 (0%)

$1,397,000 (-0.36%)

$1,402,000 (-91.22%)

Selling General & Administrative Expense

$4,744,000 (-46.71%)

$8,903,000 (-84.62%)

$57,903,000 (-28.29%)

$80,748,000 (-58.38%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$6,521,000 (-33.63%)

$9,825,000 (-85.42%)

$67,375,000 (-16.56%)

$80,748,000 (-60.50%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

-$31,000 (27.91%)

-$43,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

-$131,000 (-105.08%)

$2,579,000 (102.33%)

-$110,923,000 (-219.13%)

$93,110,000 (0%)

Consolidated Income

-$2,181,000 (78.78%)

-$10,278,000 (-109.18%)

$111,997,000 (164.96%)

-$172,415,000 (6.05%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$2,181,000 (78.78%)

-$10,278,000 (-109.18%)

$111,997,000 (164.96%)

-$172,415,000 (6.05%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$2,181,000 (78.78%)

-$10,278,000 (-109.18%)

$111,997,000 (164.96%)

-$172,415,000 (6.05%)

Weighted Average Shares

$11,532,000 (10.45%)

$10,441,000 (15.65%)

$9,028,000 (13.42%)

$7,960,000 (44.39%)

Weighted Average Shares Diluted

$11,532,000 (10.45%)

$10,441,000 (11.48%)

$9,366,000 (17.66%)

$7,960,000 (44.39%)

Earning Before Interest & Taxes (EBIT)

-$2,212,000 (78.57%)

-$10,321,000 (-109.22%)

$111,997,000 (164.96%)

-$172,415,000 (-11.28%)

Gross Profit

$1,761,000 (35.25%)

$1,302,000 (-98.10%)

$68,566,000 (5755.34%)

$1,171,000 (-97.61%)

Operating Income

-$4,760,000 (44.15%)

-$8,523,000 (-815.62%)

$1,191,000 (101.50%)

-$79,577,000 (48.84%)

TXMD Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

$223,479,000 (10153.04%)

-$2,223,000 (-39.11%)

Net Cash Flow from Financing

$0 (0%)

$3,151,000 (101.34%)

-$235,206,000 (-281.55%)

$129,552,000 (60.49%)

Net Cash Flow from Operations

$732,000 (101.52%)

-$48,141,000 (-1080.51%)

-$4,078,000 (97.14%)

-$142,693,000 (10.52%)

Net Cash Flow / Change in Cash & Cash Equivalents

$732,000 (101.63%)

-$44,990,000 (-184.66%)

-$15,805,000 (-2.87%)

-$15,364,000 (80.88%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

-$34,000 (83.57%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$221,054,000 (-301.06%)

-$55,118,000 (-213.06%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$3,151,000 (27.67%)

$2,468,000 (-98.66%)

$184,670,000 (477.54%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$264,000 (-79.23%)

$1,271,000 (-89.02%)

$11,572,000 (-36.15%)

$18,125,000 (69.73%)

Depreciation Amortization & Accretion

$509,000 (-44.79%)

$922,000 (-22.72%)

$1,193,000 (62.09%)

$736,000 (-81.90%)

TXMD Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (2.04%)

98.00% (115.38%)

45.50% (-39.66%)

Profit Margin

-123.90% (84.30%)

-789.40% (-593.07%)

160.10% (102.39%)

-6700.90% (-2268.65%)

EBITDA Margin

-96.70% (86.60%)

-721.90% (-546.17%)

161.80% (102.42%)

-6672.30% (-2768.57%)

Return on Average Equity (ROAE)

-7.90% (76.83%)

-34.10% (86.32%)

-249.20% (-175.72%)

329.10% (70.08%)

Return on Average Assets (ROAA)

-5.40% (72.86%)

-19.90% (-122.38%)

88.90% (206.85%)

-83.20% (5.56%)

Return on Sales (ROS)

-125.60% (84.16%)

-792.70% (-595.13%)

160.10% (102.39%)

-6700.90% (-2706.07%)

Return on Invested Capital (ROIC)

-7.30% (80.99%)

-38.40% (99.43%)

-6718.50% (-5584.01%)

-118.20% (-90.65%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-4.53 (-97.13%)

-2.3 (-610.22%)

0.45 (154.81%)

-0.82 (54.54%)

Price to Sales Ratio (P/S)

5.63 (-68.79%)

18.04 (2402.50%)

0.72 (-98.69%)

54.99 (969.64%)

Price to Book Ratio (P/B)

0.36 (-55.42%)

0.81 (-46.08%)

1.51 (193.31%)

-1.61 (39.37%)

Debt to Equity Ratio (D/E)

0.42 (-12.73%)

0.48 (-69.57%)

1.57 (156.01%)

-2.81 (-14.00%)

Earnings Per Share (EPS)

-0.19 (80.61%)

-0.98 (-107.90%)

12.41 (157.29%)

-21.66 (35.34%)

Sales Per Share (SPS)

0.15 (22.40%)

0.13 (-98.39%)

7.75 (2299.38%)

0.32 (-97.26%)

Free Cash Flow Per Share (FCFPS)

0.06 (101.37%)

-4.61 (-920.13%)

-0.45 (97.48%)

-17.93 (38.09%)

Book Value Per Share (BVPS)

2.37 (-15.40%)

2.81 (-27.95%)

3.89 (133.10%)

-11.76 (47.71%)

Tangible Assets Book Value Per Share (TABVPS)

2.99 (-16.05%)

3.56 (-61.47%)

9.25 (-54.64%)

20.39 (-19.79%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (-150.00%)

-2 (-300.00%)

1 (200.00%)

-1 (66.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-6.25 (-188.51%)

-2.17 (-311.83%)

1.02 (172.81%)

-1.41 (57.29%)

Asset Turnover

0.04 (76.00%)

0.03 (-95.50%)

0.56 (4525.00%)

0.01 (-96.14%)

Current Ratio

2.37 (37.88%)

1.72 (45.60%)

1.18 (150.42%)

0.47 (-78.23%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$732,000 (101.52%)

-$48,141,000 (-1080.51%)

-$4,078,000 (97.14%)

-$142,727,000 (10.62%)

Enterprise Value (EV)

$10,647,892 (-47.72%)

$20,368,290 (-82.40%)

$115,746,111 (-52.01%)

$241,185,142 (-51.42%)

Earnings Before Tax (EBT)

-$2,212,000 (78.57%)

-$10,321,000 (-109.22%)

$111,997,000 (164.96%)

-$172,415,000 (6.05%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$1,703,000 (81.88%)

-$9,399,000 (-108.30%)

$113,190,000 (165.93%)

-$171,679,000 (-13.79%)

Invested Capital

$29,818,000 (-8.43%)

$32,562,000 (717.64%)

-$5,272,000 (-112.90%)

$40,862,000 (-83.44%)

Working Capital

$7,093,000 (43.52%)

$4,942,000 (-41.94%)

$8,512,000 (106.38%)

-$133,423,000 (-292.90%)

Tangible Asset Value

$34,501,000 (-7.28%)

$37,211,000 (-55.44%)

$83,515,000 (-48.55%)

$162,328,000 (15.81%)

Market Capitalization

$9,917,892 (-58.32%)

$23,794,290 (-55.04%)

$52,921,111 (-64.97%)

$151,062,142 (-54.24%)

Average Equity

$27,699,500 (-8.10%)

$30,140,000 (167.06%)

-$44,943,500 (14.20%)

-$52,383,250 (44.76%)

Average Assets

$40,147,000 (-22.46%)

$51,773,000 (-58.91%)

$125,987,000 (-39.21%)

$207,251,750 (-0.49%)

Invested Capital Average

$30,472,750 (13.38%)

$26,875,750 (1712.22%)

-$1,667,000 (-101.14%)

$145,894,750 (-41.66%)

Shares

11,532,432 (9.05%)

10,575,240 (11.71%)

9,467,104 (11.40%)

8,498,573 (55.76%)